BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 16762827)

  • 1. Molecular cytogenetic analysis of five 2q37 deletions: refining the brachydactyly candidate region.
    Chaabouni M; Le Merrer M; Raoul O; Prieur M; de Blois MC; Philippe A; Vekemans M; Romana SP
    Eur J Med Genet; 2006; 49(3):255-63. PubMed ID: 16762827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular delineation of deletions on 2q37.3 in three cases with an Albright hereditary osteodystrophy-like phenotype.
    Shrimpton AE; Braddock BR; Thomson LL; Stein CK; Hoo JJ
    Clin Genet; 2004 Dec; 66(6):537-44. PubMed ID: 15521982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deletion 2q37.3 and autism: molecular cytogenetic mapping of the candidate region for autistic disorder.
    Lukusa T; Vermeesch JR; Holvoet M; Fryns JP; Devriendt K
    Genet Couns; 2004; 15(3):293-301. PubMed ID: 15517821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phenotypic variant of Brachydactyly-mental retardation syndrome in a family with an inherited interstitial 2q37.3 microdeletion including HDAC4.
    Villavicencio-Lorini P; Klopocki E; Trimborn M; Koll R; Mundlos S; Horn D
    Eur J Hum Genet; 2013 Jul; 21(7):743-8. PubMed ID: 23188045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Haploinsufficiency of HDAC4 causes brachydactyly mental retardation syndrome, with brachydactyly type E, developmental delays, and behavioral problems.
    Williams SR; Aldred MA; Der Kaloustian VM; Halal F; Gowans G; McLeod DR; Zondag S; Toriello HV; Magenis RE; Elsea SH
    Am J Hum Genet; 2010 Aug; 87(2):219-28. PubMed ID: 20691407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two further AHO-like syndrome patients with deletion of glypican 1 gene region in 2q37.2-q37.3.
    Polityko A; Maltseva O; Rumyantseva N; Khurs O; Seidel J; Claussen U; Weise A; Liehr T; Starke H
    Int J Mol Med; 2004 Dec; 14(6):977-9. PubMed ID: 15547662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuropsychological profiles of patients with 2q37.3 deletion associated with developmental dyspraxia.
    Ogura K; Takeshita K; Arakawa C; Shimojima K; Yamamoto T
    Am J Med Genet B Neuropsychiatr Genet; 2014 Dec; 165B(8):684-90. PubMed ID: 25329715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. STK25 is a candidate gene for pseudopseudohypoparathyroidism.
    Davids MS; Crawford E; Weremowicz S; Morton CC; Copeland NG; Gilbert DJ; Jenkins NA; Phelan MC; Comb MJ; Melnick MB
    Genomics; 2001 Sep; 77(1-2):2-4. PubMed ID: 11543625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chromosome 2q37 deletion: clinical and molecular aspects.
    Falk RE; Casas KA
    Am J Med Genet C Semin Med Genet; 2007 Nov; 145C(4):357-71. PubMed ID: 17910077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brachydactyly and mental retardation: an Albright hereditary osteodystrophy-like syndrome localized to 2q37.
    Wilson LC; Leverton K; Oude Luttikhuis ME; Oley CA; Flint J; Wolstenholme J; Duckett DP; Barrow MA; Leonard JV; Read AP
    Am J Hum Genet; 1995 Feb; 56(2):400-7. PubMed ID: 7847374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Femoral facial syndrome associated with a de novo complex chromosome 2q37 rearrangement.
    Spielmann M; Marx S; Barbi G; Flöttmann R; Kehrer-Sawatzki H; König R; Horn D; Mundlos S; Nader S; Borck G
    Am J Med Genet A; 2016 May; 170A(5):1202-7. PubMed ID: 26822876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 2q37.3 Deletion Syndrome: Two Cases with Highly Distinctive Facial Phenotype, Discordant Association with Schizophrenic Psychosis, and Shared Deletion Breakpoint Region on 2q37.3.
    Mehraein Y; Pfob M; Steinlein O; Aichinger E; Eggert M; Bubendorff V; Mannhart A; Müller S
    Cytogenet Genome Res; 2015; 146(1):33-8. PubMed ID: 26112830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The clinical and molecular features of three Turkish patients with a rare genetic disorder: 2q37 deletion syndrome.
    Gürsoy S; Kutbay YB; Özdemir TR; Hazan F
    Turk J Pediatr; 2019; 61(4):589-593. PubMed ID: 31990478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genotype and phenotype correlation in 103 individuals with 2q37 deletion syndrome reveals incomplete penetrance and supports HDAC4 as the primary genetic contributor.
    Le TN; Williams SR; Alaimo JT; Elsea SH
    Am J Med Genet A; 2019 May; 179(5):782-791. PubMed ID: 30848064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Haploinsufficiency of HDAC4 does not cause intellectual disability in all affected individuals.
    Wheeler PG; Huang D; Dai Z
    Am J Med Genet A; 2014 Jul; 164A(7):1826-9. PubMed ID: 24715439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Terminal 2q37 deletion and autistic behaviour.
    Lukusa T; Smeets E; Vogels A; Vermeesch JR; Fryns JP
    Genet Couns; 2005; 16(2):179-80. PubMed ID: 16080299
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical manifestation of chromosome 2 long arm terminal deletion--presentation of four cases].
    Szczałuba K; Obersztyn E; Ziemkiewicz K; Jamsheer A; Bocian E; Mazurczak T
    Med Wieku Rozwoj; 2007; 11(1):57-64. PubMed ID: 17965466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel microdeletion at chromosome 2q31.1-31.2 in a three-generation family presenting duplication of great toes with clinodactyly.
    Tsai LP; Liao HM; Chen YJ; Fang JS; Chen CH
    Clin Genet; 2009 May; 75(5):449-56. PubMed ID: 19459884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The 2q37-deletion syndrome: an update of the clinical spectrum including overweight, brachydactyly and behavioural features in 14 new patients.
    Leroy C; Landais E; Briault S; David A; Tassy O; Gruchy N; Delobel B; Grégoire MJ; Leheup B; Taine L; Lacombe D; Delrue MA; Toutain A; Paubel A; Mugneret F; Thauvin-Robinet C; Arpin S; Le Caignec C; Jonveaux P; Beri M; Leporrier N; Motte J; Fiquet C; Brichet O; Mozelle-Nivoix M; Sabouraud P; Golovkine N; Bednarek N; Gaillard D; Doco-Fenzy M
    Eur J Hum Genet; 2013 Jun; 21(6):602-12. PubMed ID: 23073310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Array-CGH analysis and clinical description of 2q37.3 de novo subtelomeric deletion.
    Kitsiou-Tzeli S; Sismani C; Ioannides M; Bashiardes S; Ketoni A; Touliatou V; Kolialexi A; Mavrou A; Kanavakis E; Patsalis PC
    Eur J Med Genet; 2007; 50(1):73-8. PubMed ID: 17194633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.